Wednesday, January 25, 2023 10:02:35 PM
Hope other companies clinical trials are successful so that their good news will hopefully make someone want rgbp’s iP.
Regen has no plans to do any clinical trials. Ever.
But maybe Koos can get someone from oncofakeapharma on the phone to find out if they ever will have a plan to plan on doing something with regen’s iP.
You can’t make this up. Koos the clown should just go into comedy because he’s a riot with just what a loser of a business man he is.
FACTS are stubborn things
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM